Press release: APEIRON Biologics announces changes to management and supervisory boards

Management Board to be expanded by Romana Gugenberger, PhD, as Chief Medical & Scientific Officer (CMSO) and Andreas Gerber, PhD, as Chief Operating Officer (COO)
Prof. Josef Penninger moves from the Supervisory Board to the newly created Scientific Advisory Board, which he will build up and lead as Chairman
Additional pre-clinical data show highly promising results with APN01 in various
mutation variants
APEIRON to propose Ulrich Granzer PhD as new member of the Supervisory Board at the upcoming Annual General Meeting